On December 15, 2021, Valence Discovery, an AI startup partnering with leading pharmaceutical and biotech companies, using AI and machine learning to support their drug discovery efforts, announced C$10.9 million ($8.5 million USD) in funding.
Fifty Years and Air Street Capital led the oversubscribed round with participation from Amplitude Ventures, Phoenix Venture Partners, and Abcam founder and former CEO, Jonathan Milner.
Valence Discovery intends to use this investment to build out its team, and expand the development of its platform.
A Fasken team composed of Christian Jacques, Jonathan Raizenne and Sarrah Coulibaly advised Valence Discovery in connection with this funding.
Jurisdiction
- Québec
